Association Between Carotid Plaque Length and Cardiovascular Events

Sponsor
Changhai Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05159804
Collaborator
Putuo Hospital, Shanghai University of Traditional Chinese Medicine (Other), No. 904 Hospital of the PLA Joint Logistics Support Force (Other), Gongli Hospital (Other), Yueyang Hospital, Shanghai University of Traditional Chinese medicine (Other)
3,637
5
167.9
727.4
4.3

Study Details

Study Description

Brief Summary

This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 3637 patients with coronary atherosclerosis who were confirmed by coronary angiography from January 2017 through December 2018.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients with coronary atherosclerosis who were confirmed by coronary angiography were eligible for the study. Carotid ultrasonography was simultaneously performed, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    3637 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Association Between Carotid Plaque Length and Cardiovascular Events
    Actual Study Start Date :
    Jan 1, 2017
    Actual Primary Completion Date :
    Jun 30, 2021
    Anticipated Study Completion Date :
    Dec 30, 2030

    Arms and Interventions

    Arm Intervention/Treatment
    Carotid plaque length

    Patients underwent coronary angiography and carotid ultrasonography simultaneously

    Outcome Measures

    Primary Outcome Measures

    1. Major adverse cardiovascular events [3 years]

      A composite of cardiovascular death, myocardial infarction, and stroke

    Secondary Outcome Measures

    1. Incident cardiovascular events [3 years]

      A composite of cardiovascular death, myocardial infarction, stroke, and unplanned coronary artery revascularization

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients≥18 years old, those who underwent carotid ultrasonography and first coronary angiography simultaneously.
    Exclusion Criteria:
    • Patients with known coronary artery disease, previous coronary or carotid revascularization, missing carotid ultrasound or coronary angiography results.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi Jiangsu China 214000
    2 Changhai Hospital Shanghai Shanghai China 200000
    3 Gongli Hospital Shanghai Shanghai China 200000
    4 Putuo Hospital Shanghai Shanghai China 200000
    5 Yueyang Hospital Shanghai Shanghai China 200000

    Sponsors and Collaborators

    • Changhai Hospital
    • Putuo Hospital, Shanghai University of Traditional Chinese Medicine
    • No. 904 Hospital of the PLA Joint Logistics Support Force
    • Gongli Hospital
    • Yueyang Hospital, Shanghai University of Traditional Chinese medicine

    Investigators

    • Principal Investigator: Pan Li, PhD, Changhai Hospital
    • Study Director: Jian Na, MD, Putuo Hospital
    • Study Director: Liang Chen, MD, No. 904 Hospital of the PLA Joint Logistics Support Force
    • Study Director: Wei Zhang, MD, Gongli Hospital
    • Study Director: Yawei Yang, MD, Yueyang Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Pan Li, Clinical Professor, Changhai Hospital
    ClinicalTrials.gov Identifier:
    NCT05159804
    Other Study ID Numbers:
    • CPL-2017
    First Posted:
    Dec 16, 2021
    Last Update Posted:
    Jan 6, 2022
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Pan Li, Clinical Professor, Changhai Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 6, 2022